WEISNER AIMEE S 4/A
4/A · GLAUKOS Corp · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
GLAUKOS (GKOS) Director Aimee S. Weisner Receives Award
What Happened
- Aimee S. Weisner, a director of GLAUKOS Corp (GKOS), was granted a derivative award on May 28, 2026 covering 2,987 shares. The grant is reported as an acquisition (award) with an acquisition price of $0.00 and an exercise price of $106.52 per share. The options vest in full on the one-year anniversary (May 28, 2027) and were granted under the issuer’s Director Compensation Policy.
- This filing is an amendment (Form 4A) correcting the originally reported exercise price; the initial Form 4 filed June 1, 2026 incorrectly listed the exercise price as $53.57.
Key Details
- Transaction date: 2026-05-28 (grant).
- Grant amount: 2,987 option shares; exercise price: $106.52 per share; acquisition price reported $0.00.
- Vesting: Vests in full on the one-year anniversary (per Director Compensation Policy).
- Filing: Amended Form 4A filed 2026-06-23 to correct exercise price (original filed June 1, 2026).
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes: F1 corrects exercise price; F2 confirms grant under Director Compensation Policy and one-year vesting.
Context
- This was an equity compensation award (options), not a purchase or sale of shares. Options give the holder the right to buy shares later at the exercise price ($106.52); exercising would require payment of that price and may be followed by a sale if the holder chooses. The grant is routinely used for director compensation/retention and does not, by itself, indicate a buy or sell market action.
Insider Transaction Report
Form 4/AAmended
GLAUKOS CorpGKOS
WEISNER AIMEE S
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1][F2]2026-05-28+2,987→ 2,987 totalExercise: $106.52From: 2027-05-28Exp: 2036-05-28→ Common Stock (2,987 underlying)
Footnotes (2)
- [F1]This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
- [F2]Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Signature
Diana Scherer, Attorney-in-Fact|2026-06-23